A good example of what you do. Being up something irrelevant to CYDY, pretend terrible data didn’t just get released, then post a bunch of vague promoter bullsh*t. Time for your money to go somewhere better.
Market Makers shaking the tree to dislodge retail shares before the launch of product sales in a few months. I have seen the exact scenario many times. It should be expected. Anyone not holding or buying here may want to consider if pre-revenue biotechs are an appropriate investment for them. This looks like a good time to accumulate more shares of CYDY to me. I am looking to take profits in other stocks and increase position here before the next run up. The trial was a limited success the next one will likely result in product sales. Also product may be sold overseas soon while the US trial is recruiting. The next news could come any day and trigger a run up with extra fuel from short covering.